We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

140 hedge funds and large institutions have $92.8M invested in Viking Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $637K

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

0% more funds holding

Funds holding: 140 → 140 (0)

6.66% less ownership

Funds ownership: 46.27% → 39.61% (-6.7%)

44% less capital invested

Capital invested by funds: $166M → $92.8M (-$73.5M)

Holders
140
Holders Change
–
Holders Change %
0%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
46
Reduced
34
Closed
19
Calls
$1.06M
Puts
$637K
Net Calls
+$425K
Net Calls Change
-$1.77M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$4.65M
2
PWAM
Park West Asset Management
California
+$3.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.25M
5
SCM
Sio Capital Management
New York
+$1.22M

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
-$25.3M
2
State Street
State Street
Massachusetts
-$9.93M
3
N
Nuveen
North Carolina
-$1.88M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.05M
5
UBS Group
UBS Group
Switzerland
-$918K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$15.4M +$100K +27,971 +0.5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$11M +$1.06M +296,353 +9%
PWAM
3
Park West Asset Management
California
$7.41M +$3.05M +850,000 +53%
Millennium Management
4
Millennium Management
New York
$4.51M +$4.65M +1,296,236 +630%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$4.13M +$1.12M +312,377 +29%
State Street
6
State Street
Massachusetts
$4.07M -$9.93M -2,768,391 -67%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$3.88M +$397K +110,612 +9%
Two Sigma Investments
8
Two Sigma Investments
New York
$3.73M +$1.11M +310,611 +33%
Two Sigma Advisers
9
Two Sigma Advisers
New York
$3.32M +$824K +229,600 +26%
SCM
10
Sio Capital Management
New York
$3M +$1.22M +339,016 +51%
Renaissance Technologies
11
Renaissance Technologies
New York
$2.9M +$2.6M +724,476 +298%
Northern Trust
12
Northern Trust
Illinois
$1.95M -$749K -208,903 -24%
Citadel Advisors
13
Citadel Advisors
Florida
$1.83M +$1.25M +348,646 +133%
IC
14
Ikarian Capital
Texas
$1.6M +$114K +31,787 +6%
DCM
15
DAFNA Capital Management
California
$1.34M – – –
PPA
16
Parametric Portfolio Associates
Washington
$1.1M +$556K +154,978 +74%
Morgan Stanley
17
Morgan Stanley
New York
$1.07M +$473K +131,861 +59%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$977K +$243K +67,835 +26%
Osaic Holdings
19
Osaic Holdings
Arizona
$929K +$72.6K +20,228 +23%
N
20
Nuveen
North Carolina
$855K -$1.88M -522,881 -67%
CSS
21
Cubist Systematic Strategies
Connecticut
$847K +$858K +239,182 +555%
Deutsche Bank
22
Deutsche Bank
Germany
$833K -$15.8K -4,418 -2%
Goldman Sachs
23
Goldman Sachs
New York
$781K +$622K +173,352 +199%
HF
24
HRT Financial
New York
$702K +$442K +123,108 +111%
DMKJ
25
David M. Knott Jr
$684K +$71.7K +20,000 +10%
1
2 3 4 5

VKTX Hedge Fund Activity: Q1 2022 in Review

140 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2022, worth a combined $92.8M — down 44% from $166M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VKTX positions and 19 closed out — a net gain of 2 holders — while 46 added to existing stakes and 34 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.65M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $25.3M.

  • 140 institutional investors held Viking Therapeutics (VKTX) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $92.8M of Viking Therapeutics stock for Q1 2022, down 44% quarter-over-quarter.
  • 21 funds opened new Viking Therapeutics positions in Q1 2022 and 19 closed out, a net change of +2 holders.
  • The largest Viking Therapeutics buyer in Q1 2022 was Millennium Management, an estimated $4.65M added.
  • The largest Viking Therapeutics seller in Q1 2022 was ArrowMark Colorado Holdings, an estimated $25.3M sold.

Based on aggregated 13F filings for Q1 2022.